232 related articles for article (PubMed ID: 17461445)
21. [Effect of peroxisome proliferators-activated receptor-gamma in the mechanisms of sulindac against large intestine carcinoma].
Li CF; Lv YM; Ni JH; Li J
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 39(1):72-6. PubMed ID: 17304332
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanism of protection against chemically and gamma-radiation induced apoptosis in human colon cancer cells.
Pierzchalski P; Krawiec A; Gawełko J; Pawlik WW; Konturek SJ; Gonciarz M
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():191-202. PubMed ID: 18812638
[TBL] [Abstract][Full Text] [Related]
24. [Proliferation and apoptosis effect of rosiglitazone on human ovarian cancer cell line SKOV3].
Ren QC; Peng ZL; Tan X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):217-22. PubMed ID: 19462893
[TBL] [Abstract][Full Text] [Related]
25. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
Meshkani R; Sadeghi A; Taheripak G; Zarghooni M; Gerayesh-Nejad S; Bakhtiyari S
Cell Biochem Funct; 2014 Dec; 32(8):683-91. PubMed ID: 25431031
[TBL] [Abstract][Full Text] [Related]
27. Growth inhibition and differentiation induced by peroxisome proliferator activated receptor gamma ligand rosiglitazone in human melanoma cell line A375.
Liu Y; Meng Y; Li H; Li J; Fu J; Liu Y; Chen XG
Med Oncol; 2006; 23(3):393-402. PubMed ID: 17018897
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
[TBL] [Abstract][Full Text] [Related]
29. [Induction of apoptosis of human ovarian cancer CoC1 cells by 5-allyl-7-gen-difluoromethylenechrysin through activation of peroxisome-proliferator activated receptor-gamma].
Li HZ; Cao JG; Deng YA; Xu JH; Xie WY
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2914-8. PubMed ID: 18261306
[TBL] [Abstract][Full Text] [Related]
30. Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARgamma signaling pathway.
Cao LQ; Wang XL; Wang Q; Xue P; Jiao XY; Peng HP; Lu HW; Zheng Q; Chen XL; Huang XH; Fu XH; Chen JS
Acta Pharmacol Sin; 2009 Sep; 30(9):1316-22. PubMed ID: 19684609
[TBL] [Abstract][Full Text] [Related]
31. The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
Rousseaux C; El-Jamal N; Fumery M; Dubuquoy C; Romano O; Chatelain D; Langlois A; Bertin B; Buob D; Colombel JF; Cortot A; Desreumaux P; Dubuquoy L
Carcinogenesis; 2013 Nov; 34(11):2580-6. PubMed ID: 23843037
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone--induced apoptosis in leukemia k562 cells and its mechanisms of action.
Liu JJ; Hu T; Wu XY; Wang CZ; Xu Y; Zhang Y; Xiao RZ; Lin DJ; Huang RW; Liu Q
Int J Toxicol; 2009; 28(2):123-31. PubMed ID: 19482836
[TBL] [Abstract][Full Text] [Related]
33. Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, independently of PPARγ in human glioma cells.
Lee MW; Kim DS; Kim HR; Kim HJ; Yang JM; Ryu S; Noh YH; Lee SH; Son MH; Jung HL; Yoo KH; Koo HH; Sung KW
Biochem Biophys Res Commun; 2012 Jan; 417(1):552-7. PubMed ID: 22177955
[TBL] [Abstract][Full Text] [Related]
34. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
Xiao Y; Yuan T; Yao W; Liao K
FEBS J; 2010 Feb; 277(3):687-96. PubMed ID: 20050918
[TBL] [Abstract][Full Text] [Related]
35. Apoptotic Mechanisms of Peroxisome Proliferator-Activated Receptor-γ Activation in Acinar Cells During Acute Pancreatitis.
Xu P; Lou XL; Chen C
Pancreas; 2016 Feb; 45(2):179-86. PubMed ID: 26495791
[TBL] [Abstract][Full Text] [Related]
36. Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.
Gao D; Hao G; Meng Z; Ning N; Yang G; Liu Z; Dong X; Niu X
PLoS One; 2015; 10(4):e0123724. PubMed ID: 25874449
[TBL] [Abstract][Full Text] [Related]
37. Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells.
Cerquetti L; Sampaoli C; Amendola D; Bucci B; Masuelli L; Marchese R; Misiti S; De Venanzi A; Poggi M; Toscano V; Stigliano A
Exp Cell Res; 2011 Jun; 317(10):1397-410. PubMed ID: 21376716
[TBL] [Abstract][Full Text] [Related]
38. Rosiglitazone inhibits cell proliferation by inducing G1 cell cycle arrest and apoptosis in ADPKD cyst-lining epithelia cells.
Liu Y; Dai B; Fu L; Jia J; Mei C
Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):523-30. PubMed ID: 20210794
[TBL] [Abstract][Full Text] [Related]
39. 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells.
Cerbone A; Toaldo C; Laurora S; Briatore F; Pizzimenti S; Dianzani MU; Ferretti C; Barrera G
Free Radic Biol Med; 2007 Jun; 42(11):1661-70. PubMed ID: 17462534
[TBL] [Abstract][Full Text] [Related]
40. [Pro-apoptotic effect of ciglitazone in leukemic HL-60 cells via PPARγ and P38 MAPK signaling pathway].
Liu JJ; Liu WD; Liu XD; Raj-Shrestha P; Liu PQ; Huang HQ; Wu CB; Wang CZ; Xu Y; Xiao RZ; Lin DJ; Huang RW
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(32):2270-4. PubMed ID: 21029675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
